Synovial Fibroblast 3.2: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis-diagnosed donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 2 of 2) - Dataset (ID:20235)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA1869 | Poly(I:C) | 2 | ug/mL | 3 | GM-CSF | 329.0 | 70 | ||||
N2759 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | GM-CSF | 346.0 | 61 | |
N2759 | Poly(I:C) | 2 | ug/mL | 3 | GM-CSF | 316.0 | 81 | ||||
RA1931 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | GM-CSF | 325.0 | 64 | |
RA1931 | Poly(I:C) | 2 | ug/mL | 3 | GM-CSF | 332.0 | 64 | ||||
N2586 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | GM-CSF | 368.0 | 72 | |
N2586 | Poly(I:C) | 2 | ug/mL | 3 | GM-CSF | 330.5 | 74 | ||||
RA1869 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 3 | GM-CSF | 206.5 | 122 | |
RA1869 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 3 | GM-CSF | 271.0 | 90 | |
N2759 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 3 | GM-CSF | 235.0 | 79 | |
N2759 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 3 | GM-CSF | 254.0 | 67 | |
RA1931 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 3 | GM-CSF | 235.5 | 84 | |
RA1931 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 3 | GM-CSF | 252.5 | 68 | |
N2586 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 3 | GM-CSF | 216.5 | 94 | |
N2586 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 3 | GM-CSF | 266.0 | 78 | |
RA1869 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | GM-CSF | 390.0 | 75 | |
RA1869 | IL-1 alpha | 100 | ng/mL | 3 | GM-CSF | 369.0 | 81 | ||||
N2759 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | GM-CSF | 378.0 | 82 | |
N2759 | IL-1 alpha | 100 | ng/mL | 3 | GM-CSF | 417.0 | 64 | ||||
RA1931 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | GM-CSF | 402.0 | 88 | |
RA1931 | IL-1 alpha | 100 | ng/mL | 3 | GM-CSF | 375.0 | 87 | ||||
N2586 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | GM-CSF | 379.5 | 74 | |
N2586 | IL-1 alpha | 100 | ng/mL | 3 | GM-CSF | 388.0 | 77 | ||||
RA1869 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 3 | GM-CSF | 309.0 | 69 | |
RA1869 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 3 | GM-CSF | 345.5 | 78 |